Back to search

Article

Metformin's Impact on Follistatin and Oxyntomodulin in PCOS, and Comorbidities: Secondary Analysis of a Double-Blind RCT

2023-07-06

Abstract excerpt

<h4>Background: </h4> Abnormal secretion of incretins, particularly Glucagon-like peptide 1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and oxyntomodulin (OXM), have been observed in individuals with Type 2 diabetes mellitus and PCOS. OXM plays a crucial role in metabolism, including reducing food intake and improving insulin secretion to decrease liver fat accumulation. Metformin, an insulin-sens...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
3e73281a-116b-5fbd-8d05-5fecb74d1c3b
DOI
10.21203/rs.3.rs-2996959/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Metformin's Impact on Follistatin and Oxyntomodulin in PCOS, and Comorbidities: Secondary Analysis of a Double-Blind RCTDOI 10.21203/rs.3.rs-2996959/v1
Select a neighboring publication to make it the new centre.